Court Affirms FTC’s Restriction on Health and Disease-Related Claims by POM Wonderful

Print Friendly, PDF & Email

February 5, 2015

health and disease-related claimsThe U.S. Court of Appeals for the District of Columbia Circuit recently affirmed a Federal Trade Commission (“FTC”) decision that POM Wonderful, LLC  (“POM”) deceptively advertised its products’ ability to prevent, treat, or reduce the risk of certain diseases.  The FTC had initially ruled that POM’s advertisements for POM Wonderful 100% Pomegranate Juice, and two dietary supplements containing a concentrated form of pomegranate extract, POMₓ Pills and POMₓ Liquid, which claimed to be clinically proven to have the aforementioned benefits, did not meet the standards for substantiation regarding either disease-related, or health-based claims.

The D.C. Circuit’s ruling has been hailed by FTC Chairwoman Edith Ramirez as a victory for consumers due to the Court’s requirement that POM have at least one randomized, well-controlled human clinical study as support for future disease/health benefit claims.  Notably, however, the D.C. Circuit stopped short of affirming the FTC’s order requiring POM to have two such clinical trials.  Nevertheless, the Court did note that in certain other circumstances, two such studies may be warranted.

Use Caution When Making Health and Disease-Related Claims

The ruling is a clear indication that businesses must be vigilant in gathering verifiable, scientific evidence to substantiate claims concerning the health benefits of their products.  While the D.C. Circuit’s decision was limited by particularized representations made by POM, and the evidence gathered by POM in support of its health and disease-related claims, the opinion nevertheless provides guidance on the types of substantiation required before businesses can safely make disease-related claims regarding their products.   Despite the Court’s rejection of the FTC’s two-study requirement in this instance, it would be unwise to assume that one randomized, well-controlled human clinical trial will always be sufficient in the eyes of the FTC and the courts.

As we have previously reported, the FTC has become increasingly aggressive in pursuing marketers that tout the health benefits of their products.  As such, it is imperative that businesses ensure that all of their health and disease-related claims are supported by credible and reliable clinical studies.

If you are interested in learning more about this topic or need to review your marketing practices, please email us at info@kleinmoynihan.com, or call us at (212) 246-0900.

The material contained herein is provided for information purposes only and is not legal advice, nor is it a substitute for obtaining legal advice from an attorney.  Each situation is unique, and you should not act or rely on any information contained herein without seeking the advice of an experienced attorney.

Attorney Advertising

Similar blog posts related to this topic:

US Supreme Court Allows POM Wonderful’s Deceptive Labeling Litigation Against Coca-Cola to Proceed

Rivals Pounce on Overblown Ad Claims

FTC Settles False Advertising Claims Against Health Supplement Company

David O. Klein

David O. Klein

David Klein is one of the most recognized attorneys in the telemarketing, technology, Internet marketing, sweepstakes and telecommunications fields. Skilled at counseling clients on a broad range of technology-related matters, David Klein has substantial experience in negotiating and drafting complex licensing, marketing and Internet agreements.

Schedule a Call
In The Know

Trending Topics

New York Sweepstakes Law blog- Klein Moynihan Turco

New York Sweepstakes Law: Are You Compliant?

Print Friendly, PDF & Email

In general, a lottery exists when entrants pay for the chance to win a prize. States alone reserve the right to administer lotteries. Businesses can eliminate one element of what would otherwise be an illegal lottery, in order to transform it into a legal promotional game. If the requirement to

TCPA surveys

An Ad or not an Ad: NY Weighs in on TCPA Surveys

Print Friendly, PDF & Email

Another day, another court decision that refines constitutes a Telephone Consumer Protection Act (“TCPA”) unsolicited fax advertisement. A Manhattan-based federal court recently issued a decision that removes faxed invitations to participate in a survey from the TCPA definition of advertisement. In drawing this distinction for TCPA surveys, the Court held

NY sports gambling law- Klein Moynihan Turco

Agreement Reached to Enact NY Sports Gambling Law

Print Friendly, PDF & Email

This week, Governor Andrew Cuomo and the New York State Legislature agreed to a budget deal that will bring mobile sports betting to the State through a unique NY sports gambling law.  Upon the Governor’s signature, NY sports gambling is primed to become the nation’s largest market. However, New York

UK and US Social Media Influencer Laws

UK and US Social Media Influencer Laws

Print Friendly, PDF & Email

In September of 2020, the United Kingdom’s (“UK”) Committee of Advertising Practice (“CAP”) reviewed the Instagram accounts of 122 UK-based social media influencers to determine whether content was being properly flagged as advertising in accordance with applicable social media influencer laws. This past March, the UK Advertising Standards Authority (“ASA”)

Share on facebook
Share on google
Share on twitter
Share on linkedin